Clients
Recent News
5/1/2017
Walk This Way: 3D Printing Drives New Advancements in Foot Orthotics
 »
3/17/2017

Position Available at Extera Partners

 »
12/21/2016
Pfizer makes a $6 million equity investment in new shares in BioInvent
Lund, Sweden – 21 December 2016
 »
12/13/2016
Acer Therapeutics obtains exclusive rights to NDA-enabling clinical data of the company’s lead product, VASEBRA™ (celiprolol), for the treatment of vascular Ehlers-Danlos Syndrome (vEDS)
 »